NewAmsterdam Pharma N.V. (NAMS)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

24.00

-2.00%

After-hours Dec 13, 2024, 05:54 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20
Revenue	12.76M	95.91M	-	-
Cost of Revenue	-	-	-	-
Gross Profit	12.76M	95.91M	-	-
Operating Income	-165.73M	-3.32M	-30.73M	-5.43M
Interest Income	10.22M	268.03K	361.10K	344.00K
Pretax Income	-160.25M	-21.14M	-36.71M	-5.75M
Net Income	-176.94M	-21.14M	-36.71M	-5.75M
Selling & General & Admin	29.77M	18.22M	5.27M	1.38M
Research & Development	159.42M	81.01M	25.46M	4.04M
Other Expenses	-	-	-	-
Operating Expenses	197.06M	116.78M	36.35M	5.40M
Interest Expense	6.80M	-	-	-
Selling & Marketing Expenses	4.06M	1.60M	858.39K	11.00K
Cost & Expenses	183.23M	116.78M	36.35M	5.40M
Income Tax	27.00K	-	-	-
Shares Outstanding (Basic)	82.16M	18.97M	17.75M	17.75M
Shares Outstanding (Diluted)	82.16M	18.97M	17.75M	17.75M
EPS (Basic)	-2.15	-1.11	-3.34	-1.15
EPS (Diluted)	-2.15	-1.11	-3.34	-1.15
EBITDA	-176.86M	-3.31M	-30.73M	-5.43M
Depreciation & Amortization	49.00K	8.40K	4.39K	1K